Crystal Reed-Tweedy

Crystal Reed-Tweedy serves as a Contract Specialist responsible for managing the full lifecycle of federal acquisitions, from requirements definition through contract award and administration. She plays a critical role in ensuring compliance with federal procurement regulations while advancing mission-critical objectives through strategic sourcing. Her portfolio primarily encompasses complex procurements in biological product manufacturing and scientific consulting services, requiring deep technical understanding and precise contract structuring. Reed-Tweedy routinely handles competitive and non-competitive acquisitions under FAR Part 15, with a focus on performance-based contracting and risk-mitigated solicitation strategies. Her contractor relationships are centered on firms with specialized capabilities in biopharmaceutical production and technical advisory services. While no single vendor dominates her award portfolio, she consistently engages with manufacturers holding cGMP certifications and consulting firms possessing domain expertise in life sciences and regulatory compliance. Her approach emphasizes vendor performance accountability, clear statement of work development, and post-award oversight to ensure deliverables align with agency needs. Reed-Tweedy’s contracting patterns reflect a strong preference for unrestricted competition, with 100% of her awards issued under the “No Set-Aside” category. This indicates a procurement strategy prioritizing technical merit, market competitiveness, and operational efficiency over socioeconomic set-asides. While she does not currently utilize 8(a), HUBZone, or SDVOSB programs, her approach remains fully compliant with small business subcontracting requirements and encourages broad market participation through open solicitations. Her primary NAICS focus areas—325414 for biological product manufacturing and 541690 for scientific and technical consulting services—reflect deep specialization in biopharmaceutical development and regulatory science. She procures products including therapeutic biologics, vaccines, and related manufacturing services, alongside expert advisory support for clinical trial design, quality assurance, and FDA regulatory strategy. Her technical domain expertise ensures acquisitions are structured to meet stringent compliance and safety standards in the life sciences sector.